Free Trial

Amundi Has $2.29 Million Stock Holdings in Plexus Corp. (NASDAQ:PLXS)

Plexus logo with Computer and Technology background
Remove Ads

Amundi lifted its stake in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 192.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,000 shares of the technology company's stock after acquiring an additional 9,207 shares during the quarter. Amundi owned about 0.05% of Plexus worth $2,289,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Victory Capital Management Inc. increased its position in shares of Plexus by 3.9% during the 3rd quarter. Victory Capital Management Inc. now owns 200,186 shares of the technology company's stock valued at $27,367,000 after purchasing an additional 7,483 shares during the period. CIBC Asset Management Inc bought a new stake in shares of Plexus in the 3rd quarter worth approximately $253,000. Natixis Advisors LLC lifted its stake in Plexus by 13.4% during the third quarter. Natixis Advisors LLC now owns 18,923 shares of the technology company's stock valued at $2,587,000 after purchasing an additional 2,235 shares during the last quarter. Advisors Asset Management Inc. grew its position in Plexus by 85.0% in the third quarter. Advisors Asset Management Inc. now owns 664 shares of the technology company's stock worth $91,000 after buying an additional 305 shares during the last quarter. Finally, Moran Wealth Management LLC increased its holdings in shares of Plexus by 4.0% in the third quarter. Moran Wealth Management LLC now owns 52,412 shares of the technology company's stock valued at $7,165,000 after buying an additional 1,994 shares in the last quarter. Institutional investors own 94.45% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on PLXS. Stifel Nicolaus began coverage on Plexus in a research note on Tuesday, February 4th. They set a "hold" rating and a $152.00 price objective for the company. Benchmark restated a "buy" rating and set a $165.00 price target on shares of Plexus in a report on Wednesday, January 22nd. Finally, Needham & Company LLC lifted their price objective on shares of Plexus from $162.00 to $172.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, Plexus currently has a consensus rating of "Moderate Buy" and a consensus target price of $163.00.

Get Our Latest Research Report on Plexus

Plexus Stock Performance

NASDAQ:PLXS traded down $0.88 during midday trading on Friday, reaching $128.21. The stock had a trading volume of 723,177 shares, compared to its average volume of 151,239. The stock has a market capitalization of $3.47 billion, a P/E ratio of 29.75 and a beta of 0.90. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. Plexus Corp. has a 1-year low of $90.87 and a 1-year high of $172.89. The firm's fifty day simple moving average is $140.74 and its 200-day simple moving average is $145.39.

Plexus (NASDAQ:PLXS - Get Free Report) last posted its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing analysts' consensus estimates of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. On average, equities research analysts forecast that Plexus Corp. will post 5.9 EPS for the current fiscal year.

Insider Transactions at Plexus

In other news, CEO Todd P. Kelsey sold 1,500 shares of the company's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $156.39, for a total transaction of $234,585.00. Following the completion of the transaction, the chief executive officer now owns 74,271 shares of the company's stock, valued at approximately $11,615,241.69. This represents a 1.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael J. Running sold 1,250 shares of Plexus stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $138.62, for a total value of $173,275.00. Following the sale, the insider now directly owns 1,276 shares in the company, valued at approximately $176,879.12. This trade represents a 49.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 19,458 shares of company stock worth $2,786,515 over the last three months. 1.76% of the stock is currently owned by insiders.

Plexus Profile

(Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Recommended Stories

Institutional Ownership by Quarter for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads